Re­turn of the SPAC? Bi­hua Chen and Cor­morant go for round two af­ter Moon­Lake suc­cess

Blank check com­pa­nies are large­ly dead and gone, but Bi­hua Chen and her life sci­ences in­vest­ment firm Cor­morant As­set Man­age­ment are back with a sec­ond spe­cial pur­pose ac­qui­si­tion com­pa­ny af­ter suc­cess­ful­ly com­bin­ing their first with Moon­Lake Im­munother­a­peu­tics.

Chen and Cor­morant filed for a $100 mil­lion ini­tial pub­lic of­fer­ing for their SPAC, named He­lix Ac­qui­si­tion Corp. II, on Thurs­day night. It plans to list on the Nas­daq as $HLXB and raise as much as $115 mil­lion if un­der­writ­ers ex­er­cise their over-al­lot­ment op­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER